5 Questions After Amarin's Off-Label Marketing Triumph
A landmark court decision on Friday allowing truthful and nonmisleading off-label promotion by Amarin Pharma Inc. provides a roadmap for drugmakers to market products more freely, but attorneys say much uncertainty...To view the full article, register now.
Already a subscriber? Click here to view full article